Cargando…
Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: A hospital-based retrospective evidence
CONTEXT: Role of nimotuzumab in locally advanced head and neck cancer (HNC) is well established in India; however, no clinical evidence is available for its role in recurrent and/or metastatic HNC. AIMS: The aim of this study is to evaluate the efficacy and safety of nimotuzumab when added to standa...
Autores principales: | Subramanian, Sundaram, Sridharan, Nithya, Balasundaram, V., Chaudhari, Sameer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069342/ https://www.ncbi.nlm.nih.gov/pubmed/30112336 http://dx.doi.org/10.4103/sajc.sajc_87_18 |
Ejemplares similares
-
Effectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidence
por: Subramanian, Sundaram, et al.
Publicado: (2019) -
Nimotuzumab with intensity-modulated radiation therapy in unresectable and platinum-ineligible locally advanced head-and-neck cancer
por: Srinivas, K. Satish, et al.
Publicado: (2020) -
Safety and efficacy of nimotuzumab with concurrent chemoradiotherapy in unresectable locally advanced squamous cell carcinoma of head and neck: An Indian rural hospital experience
por: Rawat, Shyamji, et al.
Publicado: (2019) -
Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: Prospective comparative study - ESCORT-N study
por: Kumar, Ashok, et al.
Publicado: (2019) -
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
por: van der Linden, Naomi, et al.
Publicado: (2015)